search
Back to results

An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas

Primary Purpose

Pancreatic Fistula, Distal Pancreatectomy Complications, Falciform Patch Pancreatic Closure

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Falciform patch and fibrin glue application
standard pancreatic closure
Sponsored by
Thomas Jefferson University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pancreatic Fistula focused on measuring pancreatectomy, fistula, fibrin glue, falciform patch, surgery, complications

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. completion of a successful distal pancreatectomy with/without splenectomy
  2. patient must have a pancreatic remnant in place
  3. there must be a viable falciform ligament for creation of the autologous patch

Exclusion Criteria:

  1. patients undergoing total pancreatectomy
  2. patients undergoing distal pancreatectomy who have previously completed a right sided resection of the pancreatic head, uncinate and neck
  3. failure to sign informed consent
  4. pregnant patients
  5. patients in whom previous surgery has eliminated the falciform ligament, i.e. previous liver resection

Sites / Locations

  • University Hospitals Case Medical CenterRecruiting
  • Thomas Jefferson UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Patch and glue arm

stapled /sutured pancreatic closure

Arm Description

Randomized patients to the patch and glue arm will undergo placement of a falciform ligament tissue patch and fibrin glue to the resection margin of the remnant pancreas following distal pancreatectomy

Outcomes

Primary Outcome Measures

Pancreatic fistula development post distal pancreatectomy

Secondary Outcome Measures

Morbidity- wound infection,delayed gastric emptying,abscess formation
Mortality
Surgical re-intervention/percutaneous interventions

Full Information

First Posted
April 27, 2009
Last Updated
August 5, 2014
Sponsor
Thomas Jefferson University
search

1. Study Identification

Unique Protocol Identification Number
NCT00889213
Brief Title
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas
Official Title
A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Unknown status
Study Start Date
August 2008 (undefined)
Primary Completion Date
December 2014 (Anticipated)
Study Completion Date
December 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Thomas Jefferson University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this trial is to determine whether the use of an autologous falciform ligament patch combined with fibrin glue will reduce the rate of pancreatic fistula in patients completing distal pancreatectomy. The hypothesis for the current trial is: Autologous falciform patch closure with fibrin glue will result in a 50% decrease in fistula formation postoperatively. The primary end point will be the development of pancreatic fistula using the ISGPF definition of pancreatic fistula1. (Drain output of any measurable volume of fluid on or after postop day #3 with an amylase content greater than three times serum amylase). Secondary end points will include length of postoperative hospital stay, percutaneous intervention rates, re-operation rates, morbidity to include delayed gastric emptying, wound infection, intraabdominal abscess, postoperative hemorrhage and 30-day mortality.(Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: An international study group (ISGPF) definition. The Journal of Surgery, 2005;138:8-13).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Fistula, Distal Pancreatectomy Complications, Falciform Patch Pancreatic Closure, Fibrin Glue Pancreatic Closure
Keywords
pancreatectomy, fistula, fibrin glue, falciform patch, surgery, complications

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
190 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patch and glue arm
Arm Type
Experimental
Arm Description
Randomized patients to the patch and glue arm will undergo placement of a falciform ligament tissue patch and fibrin glue to the resection margin of the remnant pancreas following distal pancreatectomy
Arm Title
stapled /sutured pancreatic closure
Arm Type
Active Comparator
Intervention Type
Procedure
Intervention Name(s)
Falciform patch and fibrin glue application
Intervention Description
Following standard surgical exploration, the pancreatic gland will be mobilized appropriately to the level of transaction in the pancreatic neck, body or tail. The gland may be divided by stapling device, electrocautery or sharp division. Suture material will be at the discretion of the surgeon but may include absorbable or non-absorbable braided on mono-filament. Those patients randomized to autologous falciform patch will have the falciform membrane harvested. The falciform patch will be laid over the suture line of the resected pancreatic stump and secured to the pancreatic capsule utilizing #4-0 PDS suture placed at 12, 3, 6, and 9 o'clock positions. Fibrin glue (Vitagel) will be utilized to fill the potential space within this membranous capsule. Fibrin glue will be prepared as per standard instructions. Drains will be placed in the splenic bed and/or adjacent to the stump of the pancreas for postoperative fluid evacuation.
Intervention Type
Procedure
Intervention Name(s)
standard pancreatic closure
Intervention Description
Following standard surgical exploration, the pancreatic gland will be mobilized appropriately to the level of transaction in the pancreatic neck, body or tail. The gland may be divided by stapling device, electrocautery or sharp division. Suture material will be at the discretion of the surgeon but may include absorbable or non-absorbable braided on mono-filament.
Primary Outcome Measure Information:
Title
Pancreatic fistula development post distal pancreatectomy
Time Frame
30 days post surgery
Secondary Outcome Measure Information:
Title
Morbidity- wound infection,delayed gastric emptying,abscess formation
Time Frame
30 day
Title
Mortality
Time Frame
30 day
Title
Surgical re-intervention/percutaneous interventions
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: completion of a successful distal pancreatectomy with/without splenectomy patient must have a pancreatic remnant in place there must be a viable falciform ligament for creation of the autologous patch Exclusion Criteria: patients undergoing total pancreatectomy patients undergoing distal pancreatectomy who have previously completed a right sided resection of the pancreatic head, uncinate and neck failure to sign informed consent pregnant patients patients in whom previous surgery has eliminated the falciform ligament, i.e. previous liver resection
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ernest L. Rosato, M.D.
Phone
215-955-8666
Email
ernest.rosato@jefferson.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ernest L Rosato, M.D.
Organizational Affiliation
Thomas Jefferson University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals Case Medical Center
City
Cleveland
State/Province
Ohio
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jeffrey M Hardacre, MD
Phone
216-844-7047
Email
jeffrey.hardacre@UHospitals.org
First Name & Middle Initial & Last Name & Degree
Bridget Ermlich, RN
Phone
(216) 844-3602
Email
bridget.ermlich@UHospitals.org
First Name & Middle Initial & Last Name & Degree
Jeffrey M Hardacre, MD
Facility Name
Thomas Jefferson University
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ernest L Rosato, M.D.
Phone
215-955-8666
Email
ernest.rosato@jefferson.edu
First Name & Middle Initial & Last Name & Degree
Ernest L Rosato, M.D.
First Name & Middle Initial & Last Name & Degree
Charles J Yeo, M.D.
First Name & Middle Initial & Last Name & Degree
Adam Berger, M.D.
First Name & Middle Initial & Last Name & Degree
Karen Chojnacki, M.D.
First Name & Middle Initial & Last Name & Degree
Eugene Kennedy, M.D.
First Name & Middle Initial & Last Name & Degree
Francis E Rosato, M.D.
First Name & Middle Initial & Last Name & Degree
Bernadette Profetta, M.D.

12. IPD Sharing Statement

Citations:
PubMed Identifier
22798186
Citation
Carter TI, Fong ZV, Hyslop T, Lavu H, Tan WP, Hardacre J, Sauter PK, Kennedy EP, Yeo CJ, Rosato EL. A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes? J Gastrointest Surg. 2013 Jan;17(1):102-9. doi: 10.1007/s11605-012-1963-x. Epub 2012 Jul 14.
Results Reference
derived

Learn more about this trial

An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas

We'll reach out to this number within 24 hrs